Immunomodulatory Effects and Protection in Sepsis by the Antibiotic Moxifloxacin
Sepsis is a leading cause of death in Intensive Care Units. Despite its prevalence, sepsis remains insufficiently understood, with no substantial qualitative improvements in its treatment in the past decades. Immunomodulatory agents may hold promise, given the significance of TNF-α and IL-1β as seps...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2024-08-01
|
| Series: | Antibiotics |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2079-6382/13/8/742 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|